Skin of Color
A compounded formulation with an adhesive vehicle offers an alternative to procedures for this common patient complaint.
Steven Leon, MS, PA-C; and Gennady Rubinstein, MD
Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.
Jerry Bagel, MD, FAAD; Ted Lain, MD, MBA; and Lawrence J. Green, MD
Peter Lio, MD
New insights on the critical role of maintaining the natural rhythm of skin protection and repair.
Nadine Pernodet, PhD; and Paolo Sassone-Corsi, PhD
Senators seek to support innovation and encourage responsible antibiotic prescribing.
Microbiome testing could be a clinical tool in the future.
Denise Mann, MS
There’s still much to learn, but clinicians already have tools to manipulate the microbiome.
Questions and answers about the microbiome and its role in influencing cutaneous health.
Neal Bhatia, MD, FAAD
Experts weigh in on the pressing needs of the specialty today.
Sandra Marchese Johnson, MD; Eric Bernstein, MD, MSE, FAD; Jeffrey T. S. Hsu, MD, FAAD; Doris Day, MD, FAAD; Stefan C. Weiss, MD, MBA, FAAD; Anisha Patel, MD, FAAD; and Mark A. Bechtel, MD, FAAD
The subspecialty needs to expand its workforce to continue to meet critical
Heather A. Brandling-Bennett, MD
Two dermatologists weigh in on the effects of cosmetic specialization on the specialty overall.
Suneel Chilukuri, MD; and Robert L. Buka, MD, JD
As medicine in general and dermatology specifically shifts toward
more employed physicians, it’s important to understand the options.
Kim Campbell; and Suneel Chilukuri, MD
Medicine in general lacks workforce diversity. Dermatology fares worse than
other specialties. Here’s a closer look at the problem.
Jeanine Downie, MD
The specialty is under fire. Here are some ways to keep on track.
Todd E. Schlesinger, MD
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.